Balanced Rock Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$225K Sell
620
-7
-1% -$2.4K 0.14% 93
2026
Q1
$221K Buy
+627
New +$224K 0.15% 92
2025
Q3
Sell
-736
Closed -$205K 97
2025
Q2
$205K Sell
736
-85
-10% -$24.1K 0.16% 94
2025
Q1
$256K Sell
821
-52
-6% -$15.4K 0.2% 77
2024
Q4
$228K Sell
873
-586
-40% -$174K 0.18% 81
2024
Q3
$470K Sell
1,459
-56
-4% -$18.3K 0.37% 53
2024
Q2
$473K Sell
1,515
-48
-3% -$14.1K 0.4% 51
2024
Q1
$444K Sell
1,563
-339
-18% -$99.2K 0.38% 56
2023
Q4
$548K Buy
+1,902
New +$518K 0.49% 52

Other funds holding AMGN

Balanced Rock Investment Advisors's AMGN Position: Q2 2026 in Review

Balanced Rock Investment Advisors reduced its Amgen (AMGN) stake by 1.1% in Q2 2026, selling an estimated $2.4K and leaving 620 shares worth $225K. The position accounts for 0.14% of the portfolio, ranked #93.

Balanced Rock Investment Advisors first reported a position in AMGN in Q4 2023 and has held it in 9 quarters since. The position peaked at $548K in Q4 2023. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Balanced Rock Investment Advisors held 620 shares of Amgen worth $225K as of Q2 2026.
  • Balanced Rock Investment Advisors sold 7 Amgen shares in Q2 2026, an estimated $2.4K.
  • Amgen made up 0.14% of Balanced Rock Investment Advisors's portfolio in Q2 2026, its #93 holding.
  • Balanced Rock Investment Advisors first reported a position in Amgen in Q4 2023 and has held it in 9 quarters since.
  • Balanced Rock Investment Advisors's Amgen position peaked at $548K in Q4 2023.
  • 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Balanced Rock Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.